These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 2438796)

  • 1. A quantitative enzyme immunoassay for primary fibrinogenolysis products in plasma.
    Koppert PW; Kuipers W; Hoegee-de Nobel B; Brommer EJ; Koopman J; Nieuwenhuizen W
    Thromb Haemost; 1987 Feb; 57(1):25-8. PubMed ID: 2438796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A monoclonal antibody-based enzyme immunoassay for fibrin degradation products in plasma.
    Koppert PW; Hoegee-de Nobel E; Nieuwenhuizen W
    Thromb Haemost; 1988 Apr; 59(2):310-5. PubMed ID: 3133813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
    Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
    Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New enzyme immunoassay of fibrin-fibrinogen degradation products in plasma using a monoclonal antibody.
    Koopman J; Haverkate F; Koppert P; Nieuwenhuizen W; Brommer EJ; Van der Werf WG
    J Lab Clin Med; 1987 Jan; 109(1):75-84. PubMed ID: 3540164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical evaluation of a test for plasma fibrin/fibrinogen degradation products (FDP) based on monoclonal anti-FDP antibody technology: an application for the scoring system of the disseminated intravascular coagulation (DIC) diagnostic criteria].
    Ito K; Wada H; Abe Y; Tomatsu H; Nishioka J; Nobori T
    Rinsho Byori; 2003 Apr; 51(4):295-9. PubMed ID: 12747249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis].
    Imoto K; Yasumuro Y; Taki M; Suzuki N; Tanabe H; Ichikawa Y
    Rinsho Byori; 2001 Mar; 49(3):283-9. PubMed ID: 11307330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Differentiation of fibrinolysis and fibrinogenolysis by analysis of FDP fragments].
    Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
    Rinsho Byori; 1992 Jul; 40(7):789-94. PubMed ID: 1507499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies on the fragments of FDP in 3 patients with DIC associated with acute promyelocytic leukemia].
    Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
    Rinsho Byori; 1993 Jun; 41(6):719-25. PubMed ID: 8361040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation.
    Okajima K; Uchiba M; Murakami K; Okabe H; Takatsuki K
    Am J Hematol; 1996 Mar; 51(3):186-91. PubMed ID: 8619398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinolysis and fibrinogenolysis in disseminated intravascular coagulation.
    Takahashi H; Tatewaki W; Wada K; Niwano H; Shibata A
    Thromb Haemost; 1990 Jun; 63(3):340-4. PubMed ID: 2402738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of cross-linked fibrin and fibrinogen degradation products with SDS-PAGE and immunoblot].
    Okumura N; Kagiya H; Kumagai T; Kameko M; Tozuka M; Saito H; Katsuyama T; Kanai M
    Rinsho Byori; 1990 Feb; 38(2):201-7. PubMed ID: 2329722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fluctuation of plasma levels of fibrinogen degradation products, fibrin degradation products and total fibrin/fibrinogen degradation products in patients with DIC].
    Isogai N; Kuroso K; Fujimaki M; Yorifuji H; Fukutake K
    Rinsho Byori; 1993 Dec; 41(12):1349-52. PubMed ID: 8295346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A monoclonal antibody-based quantitative enzyme immunoassay for the determination of plasma fibrinogen concentrations.
    Hoegee-de Nobel E; Voskuilen M; Briët E; Brommer EJ; Nieuwenhuizen W
    Thromb Haemost; 1988 Dec; 60(3):415-8. PubMed ID: 3070825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of crosslinked fibrin degradation products - an immunoassay using monoclonal antibodies.
    Elms MJ; Bunce IH; Bundesen PG; Rylatt DB; Webber AJ; Masci PP; Whitaker AN
    Thromb Haemost; 1983 Aug; 50(2):591-4. PubMed ID: 6356456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Differentiation between fibrin degradation products and fibrinogen degradation products by using newly developed ELISAs].
    Isogai N; Yamagishi T; Kaku M; Matsumoto K; Yamamoto Y; Kuroso K; Arai M; Yorifuji H; Fukutake K; Fujimaki M
    Rinsho Byori; 1991 Jul; 39(7):753-7. PubMed ID: 1920869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases.
    Mombelli G; Monotti R; Haeberli A; Straub PW
    Thromb Haemost; 1987 Aug; 58(2):758-63. PubMed ID: 3672428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A functional plasminogen assay utilizing the potentiating effect of fibrinogen to correct for the overestimation of plasminogen in pathological plasma samples.
    Gram J; Jespersen J
    Thromb Haemost; 1985 Apr; 53(2):255-9. PubMed ID: 4024036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fibrinogen and fibrin degradation products in the blood of acute myocardial infarct patients at the hospital rehabilitation stage].
    Solov'ev AV; Ermolin GA; Ignashenkova GV; Dikov MM
    Ter Arkh; 1987; 59(10):21-3. PubMed ID: 3324376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation.
    Horan JT; Francis CW
    Semin Thromb Hemost; 2001 Dec; 27(6):657-66. PubMed ID: 11740689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.